{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T15:59:24Z","timestamp":1778774364557,"version":"3.51.4"},"reference-count":16,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Auris Nasus Larynx"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.anl.2019.02.005","type":"journal-article","created":{"date-parts":[[2019,7,23]],"date-time":"2019-07-23T17:22:24Z","timestamp":1563902544000},"page":"896-901","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Pituitary-adrenal dysfunction caused by nivolumab for head and neck cancer"],"prefix":"10.1016","volume":"46","author":[{"given":"Kosuke","family":"Hihara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isaku","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuaki","family":"Katsube","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryota","family":"Tomioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoaki","family":"Tsukahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anl.2019.02.005_bib0001","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1056\/NEJMoa1602252","article-title":"Nivolumab for recurrent squamous-cell carcinoma of the head and neck","volume":"375","author":"Ferris","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anl.2019.02.005_bib0002","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.2169\/internalmedicine.8548-16","article-title":"Isolated adrenocorticotropic hormone deficiency caused by nivolumab in a patient with metastatic lung cancer","volume":"56","author":"Takaya","year":"2017","journal-title":"Intern Med"},{"key":"10.1016\/j.anl.2019.02.005_bib0003","first-page":"933","article-title":"Isolated ACTH deficiency probably induced by autoimmune-related mechanism evoked with nivolumab","volume":"30","author":"Kitajima","year":"2016","journal-title":"FASEB J"},{"key":"10.1016\/j.anl.2019.02.005_bib0004","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1210\/jc.2016-2118","article-title":"Hormonal replacement in hypopituitarism in adults: an Endocrine Society clinical practice guideline","volume":"101","author":"Fleseriu","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"July","key":"10.1016\/j.anl.2019.02.005_bib0005","first-page":"662","article-title":"Management of side effects of immune checkpoint blockade by anti-CTLA-4 and anti-PD-1 antibodies in metastatic melanoma","volume":"14","author":"K\u00e4hler","year":"2016","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.anl.2019.02.005_bib0006","doi-asserted-by":"crossref","first-page":"358","DOI":"10.14740\/jocmr3257w","article-title":"Isolated adrenocorticotropic hormone deficiency and severe hypercalcemia after destructive thyroiditis in a patient on nivolumab therapy with a malignant melanoma","volume":"10","author":"Takebayashi","year":"2018","journal-title":"J Clin Med Res"},{"key":"10.1016\/j.anl.2019.02.005_bib0007","doi-asserted-by":"crossref","first-page":"704","DOI":"10.2340\/00015555-2902","article-title":"Isolated adrenocorticotropic hormone deficiency in melanoma patients treated with nivolumab","volume":"98","author":"Kitano","year":"2018","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.anl.2019.02.005_bib0008","doi-asserted-by":"crossref","first-page":"527","DOI":"10.2169\/internalmedicine.9074-17","article-title":"Isolated adrenocorticotropin deficiency due to nivolumab-induced hypophysitis in a patient with advanced lung adenocarcinoma: a case report and literature review","volume":"57","author":"Ohara","year":"2018","journal-title":"Intern Med"},{"key":"10.1016\/j.anl.2019.02.005_bib0009","first-page":"115","article-title":"Secondary adrenal insufficiency following nivolumab therapy in a patient with metastatic renal cell carcinoma","volume":"42","author":"Seki","year":"2017","journal-title":"Tokai J Exp Clin Med"},{"key":"10.1016\/j.anl.2019.02.005_bib0010","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/jjco\/hyx018","article-title":"Isolated ACTH deficiency probably induced by autoimmune-related mechanism evoked with nivolumab","volume":"47","author":"Kitajima","year":"2017","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.anl.2019.02.005_bib0011","first-page":"285","article-title":"Refractory hypotension due to nivolumab-induced adrenal insufficiency","volume":"80","author":"Tsukizawa","year":"2018","journal-title":"Nagoya J Med Sci"},{"key":"10.1016\/j.anl.2019.02.005_bib0012","doi-asserted-by":"crossref","first-page":"e0159","DOI":"10.1097\/MD.0000000000010159","article-title":"Primary hypothyroidism and isolated ACTH deficiency induced by nivolumab therapy","volume":"97","author":"Zeng","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.anl.2019.02.005_bib0013","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1507\/endocrj.EJ16-0161","article-title":"Nivolumab-induced hypophysitis in a patient with advanced malignant melanoma","volume":"63","author":"Okano","year":"2016","journal-title":"Endocr J"},{"key":"10.1016\/j.anl.2019.02.005_bib0014","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1111\/1346-8138.13571","article-title":"Isolated adrenocorticotropic hormone deficiency associated with nivolumab therapy","volume":"44","author":"Narahira","year":"2017","journal-title":"J Dermatol"},{"key":"10.1016\/j.anl.2019.02.005_bib0015","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1111\/1346-8138.13532","article-title":"Isolated adrenocorticotropic hormone deficiency possibly caused by nivolumab in a metastatic melanoma patient","volume":"44","author":"Fujimura","year":"2017","journal-title":"J Dermatol"},{"key":"10.1016\/j.anl.2019.02.005_bib0016","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1507\/endocrj.EJ16-0596","article-title":"Hyponatremia can be a powerful predictor of the development of isolated ACTH deficiency associated with nivolumab treatment [Letter to the Editor]","volume":"64","author":"Cho","year":"2017","journal-title":"Endocr J"}],"container-title":["Auris Nasus Larynx"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0385814618306783?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0385814618306783?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T19:35:10Z","timestamp":1759952110000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0385814618306783"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S0385814618306783"],"URL":"https:\/\/doi.org\/10.1016\/j.anl.2019.02.005","relation":{},"ISSN":["0385-8146"],"issn-type":[{"value":"0385-8146","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pituitary-adrenal dysfunction caused by nivolumab for head and neck cancer","name":"articletitle","label":"Article Title"},{"value":"Auris Nasus Larynx","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anl.2019.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}